Drug Profile
SENS 218
Alternative Names: SENS-218Latest Information Update: 28 Feb 2019
Price :
$50
*
At a glance
- Originator Sensorion
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Ear disorders
Most Recent Events
- 28 Feb 2019 No recent reports of development identified for phase-I development in Ear disorders(In volunteers) in United Kingdom (Sublingual)
- 28 Sep 2018 No recent reports of development identified for clinical-Phase-Unknown development in Ear disorders in France (Sublingual)
- 06 Jan 2016 The Medicines and Healthcare products Regulatory Agency approves clinical trial application for phase I trial in Ear disorders